Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for Myopia
Status: | Active, not recruiting |
---|---|
Conditions: | Ocular, Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 3/9/2019 |
Start Date: | August 2006 |
End Date: | December 2020 |
A Prospective Randomized Eye to Eye Comparison of Fellow Eyes Undergoing Lasik With the IntraLase(TM) FS Versus PRK
A prospective comparison of eyes undergoing wavefront-guided LASIK in one eye and
wavefront-guided PRK in their fellow eye for myopia.
wavefront-guided PRK in their fellow eye for myopia.
This is a research study comparing the outcomes of LASIK surgery to PRK surgery for
nearsightedness when using the two different procedures. You will have one eye treated with
LASIK using the Intralase FS laser and your other eye treated with PRK. You will be one of
100 sighted patients at Stanford to undergo treatment in this clinical research trial. This
will be a prospective, randomized, research study in which up to 200 consecutive eyes
scheduled to undergo excimer laser in situ keratomileusis (LASIK) in one eye and
photorefractive keratectomy (PRK) in the fellow eye for the correction of myopia
(nearsightedness) with or without astigmatism will be enrolled. The choice of which eye
receives LASIK and which eye receives PRK will be randomized prior to enrollment.
Randomization will be done according to a randomization schedule. You will know which eye is
being treated with which procedure. The randomization will determine only whether your right
or left eye is treated with the LASIK procedure. The other eye will be treated with PRK. You
have a fifty percent chance of having your left eye treated with LASIK as your right eye.
Subjects will undergo either bilateral (both eyes at once) wavefront (a more precise custom
laser system) guided LASIK and PRK treatments using the VISX Star S4 excimer laser. All
subjects will be followed for one year after the vision correction procedure. Subjects
scheduled to undergo LASIK and PRK for the correction of myopia (nearsightedness) with or
without astigmatism will be screened for eligibility. Eligible subjects will be examined
preoperatively to establish a baseline for ocular condition (the general health and glasses
prescription of the eyes). Postoperatively, subjects will undergo an ophthalmic evaluation
(complete eye examination) at regular intervals as specified in this protocol. Retreatments
(a second operation on the same eye for residual nearsightedness) will not be allowed during
the first six months of this study. If you elect to undergo a retreatment of your LASIK or
PRK surgery prior to the 6-month post-operative visit, the retreated eye will be exited from
the study as of the retreatment date.
Any significant new finding developed during the course of the research which may relate to
the subject's willingness to continue participation will be provided to the subject or
subject's representative in a timely manner.
nearsightedness when using the two different procedures. You will have one eye treated with
LASIK using the Intralase FS laser and your other eye treated with PRK. You will be one of
100 sighted patients at Stanford to undergo treatment in this clinical research trial. This
will be a prospective, randomized, research study in which up to 200 consecutive eyes
scheduled to undergo excimer laser in situ keratomileusis (LASIK) in one eye and
photorefractive keratectomy (PRK) in the fellow eye for the correction of myopia
(nearsightedness) with or without astigmatism will be enrolled. The choice of which eye
receives LASIK and which eye receives PRK will be randomized prior to enrollment.
Randomization will be done according to a randomization schedule. You will know which eye is
being treated with which procedure. The randomization will determine only whether your right
or left eye is treated with the LASIK procedure. The other eye will be treated with PRK. You
have a fifty percent chance of having your left eye treated with LASIK as your right eye.
Subjects will undergo either bilateral (both eyes at once) wavefront (a more precise custom
laser system) guided LASIK and PRK treatments using the VISX Star S4 excimer laser. All
subjects will be followed for one year after the vision correction procedure. Subjects
scheduled to undergo LASIK and PRK for the correction of myopia (nearsightedness) with or
without astigmatism will be screened for eligibility. Eligible subjects will be examined
preoperatively to establish a baseline for ocular condition (the general health and glasses
prescription of the eyes). Postoperatively, subjects will undergo an ophthalmic evaluation
(complete eye examination) at regular intervals as specified in this protocol. Retreatments
(a second operation on the same eye for residual nearsightedness) will not be allowed during
the first six months of this study. If you elect to undergo a retreatment of your LASIK or
PRK surgery prior to the 6-month post-operative visit, the retreated eye will be exited from
the study as of the retreatment date.
Any significant new finding developed during the course of the research which may relate to
the subject's willingness to continue participation will be provided to the subject or
subject's representative in a timely manner.
Inclusion Criteria:
- Subjects age 21 and older with healthy eyes.
- Nearsightedness between -0.75 diopters and -7.00 diopters with or without astigmatism
of up to -3.50 diopters.
Exclusion Criteria:
- Subjects under the age of 21.
- Patients with thin corneas.
- Patients with topographic irregularities.
- Patients with keratoconus.
- Patients with autoimmune diseases.
- Patients who are pregnant or nursing.
- Patients must have similar levels of nearsightedness in each eye. They can not be more
than 1.0 diopter of difference between eyes.
- Patients must have similar levels of astigmatism in each eye. They can not have more
than 1.0 diopter of difference between eyes.
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials